1. "GSK Faculty"
Formats
  1. Journal Article (13834)
  2. Meeting Abstract (7076)
  3. Review (514)
  4. Book Section (342)
  5. Editorial (307)
  6. Conference Paper (162)
  7. Research Letter (96)
  8. Miscellaneous (45)
  9. Correspondence (38)
  10. Guidelines (32)
  11. Book Whole (22)
Groups
  1. GSK Faculty (22468)
  2. Sloan Kettering Institute Faculty (11482)
  3. Department of Medicine (10529)
  4. Tow Center for Developmental Oncology (TCDO) (6948)
  5. Sloan Kettering Institute Postdocs (6210)
  6. Solid Tumor Oncology Division (5880)

More Groups

People
  1. Marc Ladanyi (1327)
  2. Steven Larson (957)
  3. Jedd Wolchok (905)
  4. Cristina Antonescu (895)
  5. Kenneth Offit (788)
  6. David Solit (779)

More People

Years
  1. 2025 (296)
  2. 2024 (868)
  3. 2023 (1016)
  4. 2022 (1152)
  5. 2021 (1088)
  6. 2020 (1257)

More Years

Publications
  1. Blood (1470)
  2. Journal of Clinical Oncology (1279)
  3. Cancer Research (1104)
  4. Clinical Cancer Research (527)
  5. Modern Pathology (494)
  6. Journal of Nuclear Medicine (474)

More Publications

Publishers
  1. Nature Publishing Group (2594)
  2. American Association for Cancer Research (2194)
  3. Elsevier Inc. (1937)
  4. American Society of Hematology (1553)
  5. Cell Press (1421)
  6. American Society of Clinical Oncology (1379)

More Publishers

Results (22468)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Nanoscale nuclear environments, fine-scale 3D genome organization and transcription regulation
    Review

    Li, J.; Pertsinidis, A.
    Current Opinion in Systems Biology (2022)

    Fulltext@MSK | Save
  • Molecular subclasses of clear cell ovarian carcinoma and their impact on disease behavior and outcomes
    Editorial

    Bolton, K. L.; Chen, D.; de la Fuente, R. C.; Fu, Z.; Murali, R.; Köbel, M.; Tazi, Y.; Cunningham, J. M.; Chan, I. C. C.; Wiley, B. J.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Clinico-genomic characterization of ATM and HRD in pancreas cancer: Application for practice
    Journal Article

    Park, W.; O'Connor, C. A.; Bandlamudi, C.; Forman, D.; Chou, J. F.; Umeda, S.; Reyngold, M.; Varghese, A. M.; Keane, F.; Balogun, F.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • XL-ing at induction of apoptosis in kidney cancer through inhibition of BCL-X(L)
    Editorial

    Wang, N.; Hakimi, A. A.; Chen, Y.
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Bioinformatically expanded next-generation sequencing analysis optimizes identification of therapeutically relevant MET copy number alterations in >50,000 tumors
    Journal Article

    Solomon, J. P.; Yang, S. R.; Choudhury, N. J.; Ptashkin, R. N.; Eslamdoost, N.; Falcon, C. J.; Martin, A.; Plodkowski, A.; Wilhelm, C.; Shen, R.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Rb tumor suppressor in small cell lung cancer: Combined genomic and IHC analysis with a description of a distinct Rb-proficient subset
    Editorial

    Febres-Aldana, C. A.; Chang, J. C.; Ptashkin, R.; Wang, Y.; Gedvilaite, E.; Baine, M. K.; Travis, W. D.; Ventura, K.; Bodd, F.; Yu, H. A.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Xylose versus Bacteroides in graft-versus-host
    Editorial

    Peled, J. U.
    Cell Host & Microbe (2022)

    Fulltext@MSK | Save
  • Genetic ancestry correlates with somatic differences in a real-world clinical cancer sequencing cohort
    Journal Article

    Arora, K.; Tran, T. N.; Kemel, Y.; Mehine, M.; Liu, Y. L.; Nandakumar, S.; Smith, S. A.; Brannon, A. R.; Ostrovnaya, I.; Stopsack, K. H.; more...
    Cancer Discovery (2022)

    Fulltext@MSK | Save
  • Polymerase-epsilon exonuclease domain mutations predict excellent outcome among SWI/SNF-deficient undifferentiated and dedifferentiated endometrial carcinomas
    Meeting Abstract

    Tessier-Cloutier, B.; Köbel, M.; Momeni-Boroujeni, A.; Benhamida, J.; Stewart, C.; Ladanyi, M.; Soslow, R.; Lee, C.
    Virchows Archiv (2022)

    Fulltext@MSK | Save
  • GBM AGILE: A global, phase 2/3 adaptive platform trial to evaluate multiple treatment regimens in newly diagnosed and recurrent glioblastoma
    Meeting Abstract

    Weller, M.; Ellingson, B.; Alexander, B.; Wen, P.; Sulman, E.; Colman, H.; Berry, D.; Tanner, K.; Khasraw, M.; Lim, M.; more...
    Neuro-Oncology (2022)

    Fulltext@MSK | Save